ZTOX

Panacea Biotec (PANACEABIO): Company Update

Company Update Please find attached copies of newspaper publication of Audited Financial Results for the quarter and financial year ended March 31, 2026. Please find attached copies of newspaper publication of Audited Financial Results for the quarter and financial year ended March 31, 2026.

Panacea Biotec (PANACEABIO): Company Update

Panacea Biotec (PANACEABIO): Company Update

Company Update We would like to inform you that the Board of Directors has at its meeting held today i.e. 30.05.2026 approved the appointment of Mr. Rajinder Singh Manku as an additional director in the capacity of non-executive independent director, for a term of 5 years w.e.f. July 01, 2026. We would like to inform you that the Board of Directors has at its meeting held today i.e. 30.05.2026 approved the appointment of Mr. Rajinder Singh Manku as an additional director in the capacity of

Panacea Biotec (PANACEABIO): Company Update

Panacea Biotec (PANACEABIO): Outcome of Board Meeting

Outcome of Board Meeting Panacea Biotec Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. Panacea Biotec Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Panacea Biotec (PANACEABIO): Outcome of Board Meeting

Panacea Biotec (PANACEABIO): Company Update

Company Update We would like to inform you that the Board of Directors of the Company''s material wholly owned subsidiary, Panacea Biotec Pharma Ltd., has in its meeting held today i.e. 29.05.2026 , inter-alia, approved the appointment / re-appointment of directors. Intimation with requisite details is enclosed herewith. We would like to inform you that the Board of Directors of the Company''s material wholly owned subsidiary, Panacea Biotec Pharma Ltd., has in its meeting held today i.e. 2

Panacea Biotec (PANACEABIO): Company Update

Panacea Biotec (PANACEABIO): Company Update

Company Update Please find enclosed Secretarial Compliance Report duly issued by R&D Company Secretaries, Practicing Company Secretaries for the financial year ended March 31, 2026. Please find enclosed Secretarial Compliance Report duly issued by R&D Company Secretaries, Practicing Company Secretaries for the financial year ended March 31, 2026.

Panacea Biotec (PANACEABIO): Company Update

Panacea Biotec (PANACEABIO): General Updates

General Updates Panacea Biotec Limited has informed the Exchange about change in directors in the Company's material wholly owned subsidiary, Panacea Biotec Pharma Limited Panacea Biotec Limited has informed the Exchange about change in directors in the Company's material wholly owned subsidiary, Panacea Biotec Pharma Limited

Panacea Biotec (PANACEABIO): General Updates

Panacea Biotec (PANACEABIO): General Updates